Testosterone — Class II drug recall D-0319-2026
Ongoing recall by F.H. INVESTMENTS, Inc. (dba Asteria Health), reported 2026-02-18, distributed nationwide. Presence of Foreign substance - potential presence of metal particulate matter
| Recall number | D-0319-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | F.H. INVESTMENTS, Inc. (dba Asteria Health), Birmingham, AL, United States |
| Recall initiated | 2026-01-26 |
| Classified | 2026-02-11 |
| Reported by FDA | 2026-02-18 |
| Distributed | Nationwide (US) |
| Quantity | 60,868 pellets |
| Reason classes | specification failure |
| NDC | 79559-1037-32 |
| Lot numbers | 251000131, 251000136, 251000150, 251000158, 251000159 |
| Expiration dates | 2026-06-16, 2026-08-02, 2026-08-12, 2026-08-14 |
Product
Testosterone, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1037-32.
Reason for recall
Presence of Foreign substance - potential presence of metal particulate matter
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0319-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.